MedTrace Logo

Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos

NCT03286101 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-03-07

No results posted yet for this study

Summary

This is a randomized, double-blind, placebo-controlled clinical study evaluating the efficacy and safety of a single application of 0.5% ivermectin lotion in Filipino subjects with head lice.

Conditions

  • Pediculosis Capitis

Interventions

DRUG

0.5% Ivermectin lotion

The intervention is composed of a single application of the 0.5% ivermectin lotion.

DRUG

Vehicle

The intervention is composed of a single application of the vehicle control.

Sponsors & Collaborators

  • United Laboratories

    lead INDUSTRY

Principal Investigators

  • Gertrude Chan, M.D. · Clinical Trial Management and Testing Associates, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-14
Primary Completion
2017-10-12
Completion
2017-11-09

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03286101 on ClinicalTrials.gov